Haim Weiss - Intelicanna Chief Officer
INTL Stock | 56.00 1.80 3.11% |
Insider
Haim Weiss is Chief Officer of Intelicanna
Phone | 972 3 977 5151 |
Web | https://www.intelicanna.com |
Intelicanna Management Efficiency
The company has return on total asset (ROA) of (0.3128) % which means that it has lost $0.3128 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.4792) %, meaning that it generated substantial loss on money invested by shareholders. Intelicanna's management efficiency ratios could be used to measure how well Intelicanna manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Sarit Yohananof | M Yochananof and | 54 | |
Shiran Manor | Clal Biotechnology Industries | N/A | |
Yaackov Nadborny | B Communications | 58 | |
Lital Aharoni | B Communications | N/A | |
Yael Pri | Mivne Real Estate | N/A | |
Eyal CPA | Opal Balance | 37 | |
Ilan Sigal | Bezeq Israeli Telecommunication | 48 | |
Omer Shoor | Photomyne | 45 | |
Amit Kurland | Bezeq Israeli Telecommunication | 52 | |
Arnon MD | Clal Biotechnology Industries | 54 | |
Nir Tzemah | Photomyne | 48 | |
Meni Baruch | Bezeq Israeli Telecommunication | 48 | |
Yossi Fliva | Mivne Real Estate | N/A | |
Liron Kutzi | Photomyne | N/A | |
Yaniv Salomon | B Communications | N/A | |
Natalie Verter | Photomyne | 43 | |
Daniel Mizrahi | Opal Balance | 52 | |
Pr MD | Clal Biotechnology Industries | 77 | |
Idit Amir | Mivne Real Estate | 47 | |
Etty Kliger | Clal Biotechnology Industries | N/A | |
Tomer Raved | B Communications | 38 |
Management Performance
Return On Equity | -3.48 | |||
Return On Asset | -0.31 |
Intelicanna Leadership Team
Elected by the shareholders, the Intelicanna's board of directors comprises two types of representatives: Intelicanna inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Intelicanna. The board's role is to monitor Intelicanna's management team and ensure that shareholders' interests are well served. Intelicanna's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Intelicanna's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ilanit CPA, CFO Fin | ||
Zbigniew Brzezinski, Managing Poland | ||
Haim Weiss, Chief Officer | ||
Ori Weiss, CEO Director | ||
Zeev Ahronson, Project Procurement | ||
Elijah Weiss, Director Growth | ||
Mally BitzurParnes, Chief Israel | ||
Balfour Moore, CoFounder Director | ||
Nachshol Cohen, VP Technology | ||
Philippe Salphati, MD Swiss |
Intelicanna Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Intelicanna a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -3.48 | |||
Return On Asset | -0.31 | |||
Operating Margin | (2.86) % | |||
Current Valuation | 64.57 M | |||
Shares Outstanding | 46.96 M | |||
Shares Owned By Insiders | 34.65 % | |||
Price To Sales | 4.14 X | |||
Revenue | 4.21 M | |||
Gross Profit | (9.19 M) | |||
EBITDA | (10.67 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Intelicanna Stock
Intelicanna financial ratios help investors to determine whether Intelicanna Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Intelicanna with respect to the benefits of owning Intelicanna security.